High dose bystander effects in spatially fractionated radiation therapy

Cancer Letters

Volumn 356, Issue 1, 2015, Pages 52-57

  Asur, Rajalakshmi ^a   Butterworth, Karl T ^b   Penagaricano, Jose A ^a   Prise, Kevin M ^b   Griffin, Robert J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Bystander effects; GRID; IMRT; Spatially fractionated radiation therapy

Indexed keywords

BEAM THERAPY; BYSTANDER EFFECT; CANCER RADIOTHERAPY; CLASSIFICATION; COMPUTER ASSISTED RADIOTHERAPY; EVIDENCE BASED MEDICINE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NONHUMAN; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION FIELD; RADIATION INJURY; RADIATION RESPONSE; RADIOBIOLOGY; RADIOSENSITIVITY; SHORT SURVEY; SIGNAL TRANSDUCTION; SPATIALLY FRACTIONATED RADIATION THERAPY; TISSUE INJURY; TREATMENT RESPONSE; ADVERSE EFFECTS; ANIMAL; DNA DAMAGE; METABOLISM; MOUSE; NEOPLASMS;

REACTIVE OXYGEN METABOLITE;

ANIMALS; BYSTANDER EFFECT; DNA DAMAGE; DOSE FRACTIONATION; HUMANS; MICE; NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84912526921     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.10.032     Document Type: Review

References (65)

1. Aneja S., Pratiwadi R.R., Yu J.B. Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system. Oncology (Williston Park) 2012, 26:512-518.
2. Hingorani M., Colley W.P., Dixit S., Beavis A.M. Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?. Br. J. Radiol. 2012, 85:e770-781.
3. Laissue J.A., Blattmann H., Slatkin D.N. Alban Kohler (1874-1947): inventor of grid therapy. Z. Med. Phys. 2012, 22:90-99.
4. Penagaricano J.A., Moros E.G., Ratanatharathorn V., Yan Y., Corry P. Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:1369-1375.
5. Hricak H., Brenner D.J., Adelstein S.J., Frush D.P., Hall E.J., Howell R.W., McCollough C.H., Mettler F.A., Pearce M.S., Suleiman O.H., Thrall J.H., Wagner L.K. Managing radiation use in medical imaging: a multifaceted challenge. Radiology 2011, 258:889-905.
6. Nagasawa H., Little J.B. Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res. 1992, 52:6394-6396.
7. Mothersill C., Seymour C. Radiation-induced bystander effects: past history and future directions. Radiat. Res. 2001, 155:759-767.
8. Azzam E.I., de Toledo S.M., Little J.B. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc. Nat. Acad. Sci. USA 2001, 98:473-478.
9. Azzam E.I., de Toledo S.M., Little J.B. Oxidative metabolism, gap junctions and the ionizing radiation-induced bystander effect. Oncogene 2003, 22:7050-7057.
10. Butterworth K.T., McGarry C.K., Trainor C., O'Sullivan J.M., Hounsell A.R., Prise K.M. Out-of-field cell survival following exposure to intensity-modulated radiation fields. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79:1516-1522.
11. Mothersill C., Seymour C.B. Cell-cell contact during gamma irradiation is not required to induce a bystander effect in normal human keratinocytes: evidence for release during irradiation of a signal controlling survival into the medium. Radiat. Res. 1998, 149:256-262.
12. Yang H., Anzenberg V., Held K.D. The time dependence of bystander responses induced by iron-ion radiation in normal human skin fibroblasts. Radiat. Res. 2007, 168:292-298.
13. Prise K.M., O'Sullivan J.M. Radiation-induced bystander signalling in cancer therapy. Nat. Rev. Cancer 2009, 9:351-360.
14. Blyth B.J., Sykes P.J. Radiation-induced bystander effects: what are they, and how relevant are they to human radiation exposures?. Radiat. Res. 2011, 176:139-157.
15. Butterworth K.T., McMahon S.J., Hounsell A.R., O'Sullivan J.M., Prise K.M. Bystander signalling: exploring clinical relevance through new approaches and new models. Clin. Oncol. (R Coll. Radiol.) 2013.
16. McMahon S.J., Butterworth K.T., Trainor C., McGarry C.K., O'Sullivan J.M., Schettino G., Hounsell A.R., Prise K.M. A kinetic-based model of radiation-induced intercellular signalling. PLoS One 2013, 8:e54526.
17. Kaminski J.M., Shinohara E., Summers J.B., Niermann K.J., Morimoto A., Brousal J. The controversial abscopal effect. Cancer Treat. Rev. 2005, 31:159-172.
18. Marks H. Clinical experience with irradiation through a grid. Radiology 1952, 58:338-342.
19. Becker J., Kuttig H. The use of the grid in supervoltage therapy. Prog. Radiat. Ther. 1965, 3:50-67.
20. Zhang X., Penagaricano J., Yan Y., Sharma S., Griffin R.J., Hardee M., Han E.Y., Ratanatharathom V. Application of spatially fractionated radiation (GRID) to helical tomotherapy using a Novel TOMOGRID. TCRT Express 2013, 1.
21. Mohiuddin M., Curtis D.L., Grizos W.T., Komarnicky L. Palliative treatment of advanced cancer using multiple nonconfluent pencil beam radiation. A pilot study. Cancer 1990, 66:114-118.
22. Mohiuddin M., Fujita M., Regine W.F., Megooni A.S., Ibbott G.S., Ahmed M.M. High-dose spatially-fractionated radiation (GRID): a new paradigm in the management of advanced cancers. Int. J. Radiat. Oncol. Biol. Phys. 1999, 45:721-727.
23. Neuner G., Mohiuddin M.M., Vander Walde N., Goloubeva O., Ha J., Yu C.X., Regine W.F. High-dose spatially fractionated GRID radiation therapy (SFGRT): a comparison of treatment outcomes with Cerrobend vs. MLC SFGRT. Int. J. Radiat. Oncol. Biol. Phys. 2012, 82:1642-1649.
24. Huhn J.L., Regine W.F., Valentino J.P., Meigooni A.S., Kudrimoti M., Mohiuddin M. Spatially fractionated GRID radiation treatment of advanced neck disease associated with head and neck cancer. Technol. Cancer Res. Treat. 2006, 5:607-612.
25. Griffin R.J., Koonce N.A., Dings R.P., Siegel E., Moros E.G., Brauer-Krisch E., Corry P.M. Microbeam radiation therapy alters vascular architecture and tumor oxygenation and is enhanced by a galectin-1 targeted anti-angiogenic peptide. Radiat. Res. 2012, 177:804-812.
26. Sathishkumar S., Boyanovsky B., Karakashian A.A., Rozenova K., Giltiay N.V., Kudrimoti M., Mohiuddin M., Ahmed M.M., Nikolova-Karakashian M. Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for endothelial apoptosis. Cancer Biol. Ther. 2005, 4:979-986.
27. Sathishkumar S., Dey S., Meigooni A.S., Regine W.F., Kudrimoti M.S., Ahmed M.M., Mohiuddin M. The impact of TNF-alpha induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation. Technol. Cancer Res. Treat. 2002, 1:141-147.
28. Asur R.S., Sharma S., Chang C.W., Penagaricano J., Kommuru I.M., Moros E.G., Corry P.M., Griffin R.J. Spatially fractionated radiation induces cytotoxicity and changes in gene expression in bystander and radiation adjacent murine carcinoma cells. Radiat. Res. 2012, 177:751-765.
29. Ghandhi S.A., Ming L., Ivanov V.N., Hei T.K., Amundson S.A. Regulation of early signaling and gene expression in the alpha-particle and bystander response of IMR-90 human fibroblasts. BMC Med. Genom. 2010, 3:31.
30. Ghandhi S.A., Yaghoubian B., Amundson S.A. Global gene expression analyses of bystander and alpha particle irradiated normal human lung fibroblasts: synchronous and differential responses. BMC Med. Genom. 2008, 1:63.
31. Gao Z., Sarsour E.H., Kalen A.L., Li L., Kumar M.G., Goswami P.C. Late ROS accumulation and radiosensitivity in SOD1-overexpressing human glioma cells. Free Radical Biol. Med. 2008, 45:1501-1509.
32. Mitchell J.B., Russo A. The role of glutathione in radiation and drug induced cytotoxicity. Br. J. Cancer Suppl. 1987, 8:96-104.
33. Iyer R., Lehnert B.E., Svensson R. Factors underlying the cell growth-related bystander responses to alpha particles. Cancer Res. 2000, 60:1290-1298.
34. Lehnert B.E., Goodwin E.H. A new mechanism for DNA alterations induced by alpha particles such as those emitted by radon and radon progeny. Environ. Health Perspect. 1997, 105(Suppl. 5):1095-1101.
35. Narayanan P.K., Goodwin E.H., Lehnert B.E. Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res. 1997, 57:3963-3971.
36. Shao C., Prise K.M., Folkard M. Signaling factors for irradiated glioma cells induced bystander responses in fibroblasts. Mutat. Res. 2008, 638:139-145.
37. Konopacka M., Rzeszowska-Wolny J. The bystander effect-induced formation of micronucleated cells is inhibited by antioxidants, but the parallel induction of apoptosis and loss of viability are not affected. Mutat. Res. 2006, 593:32-38.
38. Lyng F.M., Maguire P., McClean B., Seymour C., Mothersill C. The involvement of calcium and MAP kinase signaling pathways in the production of radiation-induced bystander effects. Radiat. Res. 2006, 165:400-409.
39. Barcellos-Hoff M.H., Brooks A.L. Extracellular signaling through the microenvironment: a hypothesis relating carcinogenesis, bystander effects, and genomic instability. Radiat. Res. 2001, 156:618-627.
40. Butterworth K.T., McGarry C.K., Clasie B., Carabe-Fernandez A., Schuemann J., Depauw N., Tang S., McMahon S.J., Schettino G., O'Sullivan J.M., Lu H.M., Kooy H., Paganetti H., Hounsell A.R., Held K.D., Prise K.M. Relative biological effectiveness (RBE) and out-of-field cell survival responses to passive scattering and pencil beam scanning proton beam deliveries. Phys. Med. Biol. 2012, 57:6671-6680.
41. McGarry C.K., Butterworth K.T., Trainor C., McMahon S.J., O'Sullivan J.M., Prise K.M., Hounsell A.R. In-vitro investigation of out-of-field cell survival following the delivery of conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) plans. Phys. Med. Biol. 2012, 57:6635-6645.
42. Sjostedt S., Bezak E., Marcu L. Experimental investigation of the cell survival in dose cold spot. Acta Oncol. 2013.
43. Staffurth J. A review of the clinical evidence for intensity-modulated radiotherapy. Clin. Oncol. (R Coll. Radiol.) 2010, 22:643-657.
44. Hall E.J., Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56:83-88.
45. Ruben J.D., Davis S., Evans C., Jones P., Gagliardi F., Haynes M., Hunter A. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:1530-1536.
46. Suchowerska N., Ebert M.A., Zhang M., Jackson M. In vitro response of tumour cells to non-uniform irradiation. Phys. Med. Biol. 2005, 50:3041-3051.
47. Mackonis E.C., Suchowerska N., Zhang M., Ebert M., McKenzie D.R., Jackson M. Cellular response to modulated radiation fields. Phys. Med. Biol. 2007, 52:5469-5482.
48. Syme A A., Kirkby C., Mirzayans R., MacKenzie M., Field C., Fallone B.G. Relative biological damage and electron fluence in and out of a 6 MV photon field. Phys Med Biol. 2009, 54:6623-6633.
49. Butterworth K.T., McGarry C.K., O'Sullivan J.M., Hounsell A.R., Prise K.M. A study of the biological effects of modulated 6MV radiation fields. Phys. Med. Biol. 2010, 55:1607-1618.
50. Trainor C., Butterworth K.T., McGarry C.K., McMahon S.J., O'Sullivan J.M., Hounsell A.R., Prise K.M. DNA damage responses following exposure to modulated radiation fields. PLoS One 2012, 7:e43326.
51. Chai Y., Hei T.K. Radiation induced bystander effect in vivo. Acta Med. Nagasakiensia 2008, 53:S65-S69.
52. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radical Biol. Med. 1994, 16:99-109.
53. Lindholm C., Acheva A., Salomaa S. Clastogenic plasma factors: a short overview. Radiat. Environ. Biophys. 2010, 49:133-138.
54. Mole R.H. Whole body irradiation; radiobiology or medicine?. Br. J. Radiol. 1953, 26:234-241.
55. Camphausen K., Moses M.A., Menard C., Sproull M., Beecken W.D., Folkman J., O'Reilly M.S. Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 2003, 63:1990-1993.
56. Koturbash I., Rugo R.E., Hendricks C.A., Loree J., Thibault B., Kutanzi K., Pogribny I., Yanch J.C., Engelward B.P., Kovalchuk O. Irradiation induces DNA damage and modulates epigenetic effectors in distant bystander tissue in vivo. Oncogene 2006, 25:4267-4275.
57. Mancuso M., Pasquali E., Leonardi S., Tanori M., Rebessi S., Di Majo V., Pazzaglia S., Toni M.P., Pimpinella M., Covelli V., Saran A. Oncogenic bystander radiation effects in patched heterozygous mouse cerebellum. Proc. Nat. Acad. Sci. USA 2008, 105:12445-12450.
58. Verhaegen F., Granton P., Tryggestad E. Small animal radiotherapy research platforms. Phys. Med. Biol. 2011, 56:R55-83.
59. Demidem A., Morvan D., Madelmont J.C. Bystander effects are induced by CENU treatment and associated with altered protein secretory activity of treated tumor cells: a relay for chemotherapy?. Int. J. Cancer 2006, 119:992-1004.
60. Alexandre J., Hu Y., Lu W., Pelicano H., Huang P. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res. 2007, 67:3512-3517.
61. Asur R.S., Thomas R.A., Tucker J.D. Chemical induction of the bystander effect in normal human lymphoblastoid cells. Mutat. Res. 2009, 676:11-16.
62. Rugo R.E., Almeida K.H., Hendricks C.A., Jonnalagadda V.S., Engelward B.P. A single acute exposure to a chemotherapeutic agent induces hyper-recombination in distantly descendant cells and in their neighbors. Oncogene 2005, 24:5016-5025.
63. Dahle J., Angell-Petersen E., Steen H.B., Moan J. Bystander effects in cell death induced by photodynamic treatment UVA radiation and inhibitors of ATP synthesis. Photochem. Photobiol. 2001, 73:378-387.
64. Dabrowska A., Gos M., Janik P. "Bystander effect" induced by photodynamically or heat-injured ovarian carcinoma cells (OVP10) in vitro. Med. Sci. Monit. 2005, 11:BR316-324.
65. Chakraborty A., Held K.D., Prise K.M., Liber H.L., Redmond R.W. Bystander effects induced by diffusing mediators after photodynamic stress. Radiat. Res. 2009, 172:74-81.